Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study).
Tamura Y, Kaga H, Abe Y, Yoshii H, Seino H, Hiyoshi T, Kuribayashi N, Inoue I, Watada H. Tamura Y, et al. Among authors: hiyoshi t. Nutrients. 2023 Jun 24;15(13):2866. doi: 10.3390/nu15132866. Nutrients. 2023. PMID: 37447194 Free PMC article. Clinical Trial.
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).
Fuchigami A, Shigiyama F, Kitazawa T, Okada Y, Ichijo T, Higa M, Hiyoshi T, Inoue I, Iso K, Yoshii H, Hirose T, Kumashiro N. Fuchigami A, et al. Among authors: hiyoshi t. Cardiovasc Diabetol. 2020 Jan 7;19(1):1. doi: 10.1186/s12933-019-0977-z. Cardiovasc Diabetol. 2020. PMID: 31910850 Free PMC article. Clinical Trial.
Effects of linagliptin vs. voglibose on daily glucose excursions during continuous glucose monitoring of Japanese type 2 diabetes patients (L-CGM): A randomized, open-label, two-arm, parallel comparative trial.
Satoh H, Ohira T, Moriya C, Inoue I, Kuribayashi S, Seino H, Hirai H, Hiyoshi T, Watada H; L-CGM Study Group. Satoh H, et al. Among authors: hiyoshi t. Diabetes Metab. 2017 Dec;43(6):550-553. doi: 10.1016/j.diabet.2017.07.010. Epub 2017 Sep 22. Diabetes Metab. 2017. PMID: 28947255 Clinical Trial. No abstract available.
Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP study.
Goto H, Mita T, Fujitani Y, Fujimoto S, Takahashi K, Satoh H, Hirose T, Hiyoshi T, Ai M, Okada Y, Nishimura H, Kuroda H, Matsubara T, Gosho M, Ishii H, Watada H. Goto H, et al. Among authors: hiyoshi t. Endocr J. 2018 Jun 27;65(6):657-668. doi: 10.1507/endocrj.EJ18-0088. Epub 2018 Apr 10. Endocr J. 2018. PMID: 29643323 Free article. Clinical Trial.
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP).
Fujitani Y, Fujimoto S, Takahashi K, Satoh H, Hirose T, Hiyoshi T, Ai M, Okada Y, Gosho M, Mita T, Watada H. Fujitani Y, et al. Among authors: hiyoshi t. Diabetes Res Clin Pract. 2016 Nov;121:146-156. doi: 10.1016/j.diabres.2016.09.014. Epub 2016 Sep 22. Diabetes Res Clin Pract. 2016. PMID: 27710821 Clinical Trial.
Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).
Katsuno T, Shiraiwa T, Iwasaki S, Park H, Watanabe N, Kaneko S, Terasaki J, Hanafusa T, Imagawa A, Shimomura I, Ikegami H, Koyama H, Namba M, Miyagawa JI; TRUST2 study group. Katsuno T, et al. Adv Ther. 2021 Mar;38(3):1514-1535. doi: 10.1007/s12325-021-01631-y. Epub 2021 Jan 28. Adv Ther. 2021. PMID: 33507500 Clinical Trial.
117 results